Cargando…

Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma

RNA-binding motif protein 8A (RBM8A) is abnormally overexpressed in hepatocellular carcinoma (HCC) and involved in the epithelial-mesenchymal transition (EMT). The EMT plays an important role in the development of drug resistance, suggesting that RBM8A may be involved in the regulation of oxaliplati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Rong, Zhang, Jinyan, Liu, Zhihui, Liu, Ziyu, Li, Qian, Luo, Xiaoling, Li, Yongqiang, Ye, Jiazhou, Lin, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862710/ https://www.ncbi.nlm.nih.gov/pubmed/33552961 http://dx.doi.org/10.3389/fonc.2020.585452

Ejemplares similares

Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
por: Liu, Ziyu, et al.
Publicado: (2019)

Expression and gene regulation network of RBM8A in hepatocellular carcinoma based on data mining
por: Lin, Yan, et al.
Publicado: (2019)

RBM8A Promotes Glioblastoma Growth and Invasion Through the Notch/STAT3 Pathway
por: Lin, Yan, et al.
Publicado: (2021)

RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5
por: Gao, Xing, et al.
Publicado: (2023)

Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis
por: Zhang, Jinyan, et al.
Publicado: (2018)

Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma
por: Ye, Jiazhou, et al.
Publicado: (2022)

RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma
por: Ye, Jiazhou, et al.
Publicado: (2018)

Effective Treatment of Low-Grade Myofibroblastic Sarcoma with Apatinib: A Case Report and Literature Review
por: Lin, Yan, et al.
Publicado: (2022)

RBM10 Regulates Tumor Apoptosis, Proliferation, and Metastasis
por: Cao, Yingshu, et al.
Publicado: (2021)

Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis
por: Chen, Xinyu, et al.
Publicado: (2021)

RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma
por: Liu, Bing, et al.
Publicado: (2021)

Eukaryotic Initiation Factor 4A-3: A Review of Its Physiological Role and Involvement in Oncogenesis
por: Ye, Jiazhou, et al.
Publicado: (2021)

Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma
por: Liang, Run-Bin, et al.
Publicado: (2021)

Identification of molecular correlations of RBM8A with autophagy in Alzheimer's disease
por: Zou, Donghua, et al.
Publicado: (2019)

Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma
por: Zhang, Yong-Fa, et al.
Publicado: (2021)

Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin
por: Wang, Xiumei, et al.
Publicado: (2020)

YY1-Targeted RBM15B Promotes Hepatocellular Carcinoma Cell Proliferation and Sorafenib Resistance by Promoting TRAM2 Expression in an m6A-Dependent Manner
por: Tan, Chunzhong, et al.
Publicado: (2022)

Molecular Insights and Prognosis Associated With RBM8A in Glioblastoma
por: Wei, Lei, et al.
Publicado: (2022)

High-Affinity Human Anti-c-Met IgG Conjugated to Oxaliplatin as Targeted Chemotherapy for Hepatocellular Carcinoma
por: Ma, Yilan, et al.
Publicado: (2019)

Optimization of eIF4E-Binding Peptide Pep8 to Disrupt the RBM38-eIF4E Complex for Induction of p53 and Tumor Suppression
por: Lucchesi, Christopher A., et al.
Publicado: (2022)

Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes
por: Liu, Ziyu, et al.
Publicado: (2020)

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
por: Siesing, Christina, et al.
Publicado: (2017)

Research progress on GP73 in malignant tumors
por: Liang, Rong, et al.
Publicado: (2018)

A twenty gene-based gene set variation score reflects the pathological progression from cirrhosis to hepatocellular carcinoma
por: Lin, Yan, et al.
Publicado: (2019)

Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma
por: Zheng, Xia, et al.
Publicado: (2021)

β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1
por: Li, Xiaoqiang, et al.
Publicado: (2016)

A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases
por: Feng, Ai-Wei, et al.
Publicado: (2022)

Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma
por: Li, Can, et al.
Publicado: (2020)

Phylogenetic and Molecular Characterization of the Splicing Factor RBM4
por: Lu, Chia-Chen, et al.
Publicado: (2013)

Idiosyncratic Reaction with Cytokine Storm Associated with Oxaliplatin
por: Dembla, Vikas
Publicado: (2016)

A New Oxaliplatin Resistance-Related Gene Signature With Strong Predicting Ability in Colon Cancer Identified by Comprehensive Profiling
por: Lin, Qiu, et al.
Publicado: (2021)

Fluorouracil Supplemented With Oxaliplatin or Irinotecan for Solid Tumors: Indications From Clinical Characteristics and Health Outcomes of Patients
por: Qingwei, Zhao, et al.
Publicado: (2020)

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy
por: Chen, Jian-yao, et al.
Publicado: (2017)

Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study
por: Yu, Zaoqin, et al.
Publicado: (2021)

Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma
por: Kang, Xiaofeng, et al.
Publicado: (2022)

The hepatoprotective role of reduced glutathione and its underlying mechanism in oxaliplatin-induced acute liver injury
por: Lin, Youzhi, et al.
Publicado: (2018)

A Comprehensive Pan-Cancer Analysis of RBM8A Based on Data Mining
por: Mei, Nan, et al.
Publicado: (2021)

Reversible Ocular Toxicity of Oxaliplatin: A Case Report
por: Noor, Arish, et al.
Publicado: (2019)

A Prognostic Model Based on RNA Binding Protein Predicts Clinical Outcomes in Hepatocellular Carcinoma Patients
por: Man, Zhongsong, et al.
Publicado: (2021)

A Study on Mesoporous Silica Loaded With Novel Photosensitizers HCE6 and Oxaliplatin for the Treatment of Cholangiocarcinoma
por: Zhang, Pei-Jian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3iovmk3t51kee8qa43okarc7u9